Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Non-Current Assets: 2015-2020

Historic Non-Current Assets for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $2.0 million.

  • Outlook Therapeutics' Non-Current Assets fell 86.06% to $2.0 million in Q2 2020 from the same period last year, while for Jun 2020 it was $2.0 million, marking a year-over-year decrease of 86.06%. This contributed to the annual value of $3.6 million for FY2019, which is 80.86% down from last year.
  • Latest data reveals that Outlook Therapeutics reported Non-Current Assets of $2.0 million as of Q2 2020, which was down 45.50% from $3.7 million recorded in Q1 2020.
  • In the past 5 years, Outlook Therapeutics' Non-Current Assets ranged from a high of $21.0 million in Q2 2018 and a low of $2.0 million during Q2 2020.
  • Moreover, its 3-year median value for Non-Current Assets was $14.7 million (2019), whereas its average is $12.0 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first surged by 31.46% in 2018, then plummeted by 86.06% in 2020.
  • Quarterly analysis of 5 years shows Outlook Therapeutics' Non-Current Assets stood at $17.3 million in 2016, then fell by 2.00% to $16.9 million in 2017, then fell by 3.09% to $16.4 million in 2018, then crashed by 76.34% to $3.9 million in 2019, then plummeted by 86.06% to $2.0 million in 2020.
  • Its Non-Current Assets was $2.0 million in Q2 2020, compared to $3.7 million in Q1 2020 and $3.9 million in Q4 2019.